AAAAAA

   
Results: 1-12 |
Results: 12
Randomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinoma
Authors: White, SG Lorigan, P Middleton, MR Anderson, H Valle, J Summers, Y Burt, PA Arance, A Stout, R Thatcher, N
Citation: Sg. White et al., Randomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinoma, CANCER, 92(3), 2001, pp. 601-608
Adjuvant interferon in melanoma - a resurrection?
Authors: Middleton, MR Thatcher, N
Citation: Mr. Middleton et N. Thatcher, Adjuvant interferon in melanoma - a resurrection?, BR J CANC, 84(9), 2001, pp. 1141-1142
Post hoc economic analysis of temozolomide versus dacarbazine in the treatment of advanced metastatic melanoma
Authors: Hillner, BE Agarwala, S Middleton, MR
Citation: Be. Hillner et al., Post hoc economic analysis of temozolomide versus dacarbazine in the treatment of advanced metastatic melanoma, J CL ONCOL, 18(7), 2000, pp. 1474-1480
Temozolomide for advanced, metastatic melanoma - Reply
Authors: Middleton, MR
Citation: Mr. Middleton, Temozolomide for advanced, metastatic melanoma - Reply, J CL ONCOL, 18(10), 2000, pp. 2185-2185
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
Authors: Middleton, MR Grob, JJ Aaronson, N Fierlbeck, G Tilgen, W Seiter, S Gore, M Aamdal, S Cebon, J Coates, A Dreno, B Henz, M Schadendorf, D Kapp, A Weiss, J Fraass, U Statkevich, P Muller, M Thatcher, N
Citation: Mr. Middleton et al., Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma, J CL ONCOL, 18(1), 2000, pp. 158-166
Four-hourly scheduling of temozolomide improves tumour growth delay but not therapeutic index in A375M melanoma xenografts
Authors: Middleton, MR Kelly, J Goodger, S Thatcher, N Margison, GP
Citation: Mr. Middleton et al., Four-hourly scheduling of temozolomide improves tumour growth delay but not therapeutic index in A375M melanoma xenografts, CANC CHEMOT, 45(1), 2000, pp. 15-20
O-6-methylguanine formation, repair protein depletion and clinical outcomewith a 4 hr schedule of temozolomide in the treatment of advanced melanoma: Results of phase II study
Authors: Middleton, MR Lee, SM Arance, A Wood, M Thatcher, N Margison, GP
Citation: Mr. Middleton et al., O-6-methylguanine formation, repair protein depletion and clinical outcomewith a 4 hr schedule of temozolomide in the treatment of advanced melanoma: Results of phase II study, INT J CANC, 88(3), 2000, pp. 469-473
O-6-(4-bromothenyl)guanine improves the therapeutic index of temozolomide against A375M melanoma xenografts
Authors: Middleton, MR Kelly, J Thatcher, N Donnelly, DJ McElhinney, RS McMurry, TBH McCormick, JE Margison, GP
Citation: Mr. Middleton et al., O-6-(4-bromothenyl)guanine improves the therapeutic index of temozolomide against A375M melanoma xenografts, INT J CANC, 85(2), 2000, pp. 248-252
A randomized phase III study comparing decarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma
Authors: Middleton, MR Lorigan, P Owen, J Ashcroft, L Lee, SM Harper, P Thatcher, N
Citation: Mr. Middleton et al., A randomized phase III study comparing decarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma, BR J CANC, 82(6), 2000, pp. 1158-1162
Adjuvant interferon in the treatment of melanoma - Reply
Authors: Middleton, MR
Citation: Mr. Middleton, Adjuvant interferon in the treatment of melanoma - Reply, BR J CANC, 82(10), 2000, pp. 1755-1756
Adjuvant interferon in the treatment of melanoma
Authors: Middleton, MR
Citation: Mr. Middleton, Adjuvant interferon in the treatment of melanoma, BR J CANC, 80(11), 1999, pp. 1679-1680
Inactivation of O-6-alkylguanine-DNA alkyltransferase. 1. Novel O-6-(hetarylmethyl)guanines having basic rings in the side chain
Authors: McElhinney, RS Donnelly, DJ McCormick, JE Kelly, J Watson, AJ Rafferty, JA Elder, RH Middleton, MR Willington, MA McMurry, TBH Margison, GP
Citation: Rs. Mcelhinney et al., Inactivation of O-6-alkylguanine-DNA alkyltransferase. 1. Novel O-6-(hetarylmethyl)guanines having basic rings in the side chain, J MED CHEM, 41(26), 1998, pp. 5265-5271
Risultati: 1-12 |